Keyword: Abeona Therapeutics
In an 18-month span, Abeona lost its CEO and faced an FDA trial hold, and now its CSO and president is hitting the exit.
Just under a year ago, Abeona rejected its CEO; now, it’s the biotech’s turn to be spurned, as the FDA has slapped the company with a clinical hold.
EUSA Pharma has added two biopharma veterans to its roster, one coming after being fired from his old job and the other a top Pfizer scientist.
Sanofi's CMO takes on chief digital officer role; Parexel nabs four high-profile FDA staffers; and Nimbus poaches Janssen's discovery head as CSO.
João Siffert, M.D., has been given the permanent CEO job at Abeona Therapeutics after serving as interim chief.
Abeona fires CEO Carsten Thiel; MHRA CEO to leave in wake of Brexit; Lilly CMO to lead Brickell Bio; and Janssen's discovery head joins Incyte.
Abeona CEO Carsten Thiel has been summarily sacked after an investigation into “allegations of misconduct towards colleagues.”
Abeona will pay at least $40 million for the right to use the vector in gene therapies against forms of Sanfilippo syndrome and Batten disease.
Celgene COO Scott Smith resigns, ex-Kite leaders Belldegrun and Chang form new CAR-T shop, GSK Dermatology exec jumps to Dermavant.
Abeona is tapping industry vet Carsten Thiel, Ph.D., for its new leader in the cell and gene therapy space, with an eye to the commercial future.